High expression of EZH2 is found in breast cancer (Jang et al., 2016), prostate cancer (Wu et al., 2016), pancreatic cancer (Kuroki et al., 2014), gastric cancer (Guo et al., 2014), and other malignant tumors. Here, EZH2 is linked to cancer.